The chemical agent alloxan has been used extensively as an experimental model for diabetes mellitus in animals, as it exhibits highly selective cytotoxicity for the pancreatic beta cells [1] . Several investigators suggested that the diabetogenic action of alloxan is mediated by the generation of toxic oxygen containing species [2] [3] [4] [5] [6] [7] . These likely include H202, formed during the autooxidation of dialuric acid and the more toxic OH-radical generated from the metal-catalysed Haber-Weiss reaction [7] .
Copper-zinc superoxide dismutase (CuZn SOD, superoxide oxidoreductase, EC1.15.1.1), an enzyme which scavenges the toxic superoxide anion, is present in cells of the islets of Langerhans [8] [9] [10] . The diabetogenic action of alloxan has been shown to be attenuated in vitro and in vivo by CuZn SOD and other oxygen radical scavengers [11] [12] [13] . In contrast to CuZn SOD, cyanide inactivated SOD did not protect islets against alloxan, suggesting that the protective effect was dependent upon enzymatic activity [14] .
By bioassay and by radioimmunoassay of both CuZn and Mn-SOD the SOD content of islets in rodents is relatively low when compared to other tissues [15] . However, by immunostaining, canine and human islets appear to be richer in CuZn SOD than the exocrine pancreas [8] [9] [10] , yet the CuZn SOD content of human pancreas is about average as compared to other tissues [16] . In addition to damaging islets directly via released oxygen radicals, alloxan may inhibit the enzyme activity of CuZn SOD of tissues [17] including islets.
Several authors have reported the ultrastructural morphological effects of diabetogenic doses of alloxan on cells of the islets of Langerhans. The earliest change noted is a general swelling of fl cells [18] . An initial increase in granulation of/3 cells is followed by dissolution of the granules. Vacuole formation, mitochondrial swelling, nuclear pyknosis, and disintegration of the cell membrane all occur within 2 h after alloxan treatment. ct and ~ cells, on the other hand, appear unaffected by alloxan. Such results have been published for the dog [19] , rabbit [20] [21] [22] , mouse [23] , rat [24] , hamster [25] , and bat [26] . However, the fine structural changes in islets from animals protected with SOD from the diabetic effects of alloxan treatment have not been investigated. Such information would serve to elucidate the mechanism of protection of SOD and the mode of action of alloxan. The present study compares the fine structure of pancreatic islets in rats exposed to alloxan with and without CuZn SOD and undertakes to determine by autoradiography of labelled SOD the distribution of the injected enzyme and its possible site of action.
Materials and methods

Treatment of animals
Male Wistar rats (100-200 g) were fasted for 18 h before treatment with alloxan. Four experimental groups (n = 5-11) received, by injection via the tail vein, one of the following, each in 0.5 ml sterile phosphate-buffered saline (PBS): (1) 50mg/kg freshly dissolved alloxan (4) 35 mg/kg canine CuZn SOD followed by 50 mg/kg alloxan monohydrate in 15 rain. For SOD autoradiography, 80 Ix Ci of the iodinated enzyme was administered via tail vein in 1 ml PBS to six rats of about a00g weight. All animals were anaesthetised by methoxyflurane vapor (Metofane, PitmanMoore, Washington Crossing, New Jersey) before injection and killed by cervical dislocation. Animals from each group (n=3-5) were killed at 30 min or 5 days after injection. Blood samples were drawn from the vena cava for glucose analysis on a Glucose Analyzer 2 (Beckman, Norcross, Georgia), and samples of pancreas were collected and prepared for both light microscope immunocytochemistry and electron microscopy. For autoradiography, animals were killed 10, 50 or 120 rain post-injection.
Iodinated SOD
Bovine CuZn SOD was labelled with 125I by the chloramine-T method [27] , and separated from unbound 125I on a G-50 Sephadex column. The product was identified as ~25I-SOD by polyacrylamide gel electrophoresis (7.5%), followed by staining for SOD enzymatic activity [28, 29] . Serial gel slices (5 mm) were counted; radioactivity was associated exclusively with the SOD band. a2sI-SOD was diluted with carrier SOD to yield a specific activity of 12.5 mCi/mg.
Histologie preparation and immunocytochemical staining
Tissue sections of pancreas (1-2 mm thick) were immersed 2 h in 4% paraformaldehyde buffered with 2% calcium acetate, rinsed in run- Fig.3 . In an islet 5 days after treatment with CuZn SOD and alloxan, typical profiles of a (A, dense, thin-rimmed granules), fl (B, dense, widerimmed granules), and fi (D, moderately-dense, rimless granules) cells are present. These cell types exhibited the same morphological characteristics in islets from control and CuZn SOD-treated animals ( x 4,000) ning water for 2 h to remove excess formalin, dehydrated through a graded series of ethyl alcohols and embedded in paraffin. Adjacent sections were stained immunocytochemically by a modified immunoenzyme bridge technique [30, 31] which employed the avidin-biotinperoxidase complex (ABC, Vector Labs., Burlingame, California) method [31] , described in detail elsewhere [10] . Antisera against glucagon, insulin, and somatostatin (Dako Corp., Santa Barbara, California) were used to identify c~, fl and fi cells, respectively.
Portions of pancreas were also prepared for electron microscopic examination. Ten pieces (1 mm 3) from the tail of the pancreas from each animal were fixed 2 h in 2.5% glutaraldehyde in 0A M phosphate buffer (pH 7.2), post-fixed 1 h in 2% OsO4 in phosphate buffer, rinsed, dehydrated, and embedded in Epon812. Islets were identified in thick sections, then thin-sectioned, stained with uranyl acetate and lead citrate [32] , and photographed in an electron microscope (model 100-S, JEOL, Tokyo, Japan).
For autoradiography, lung, liver, kidney and pancreas were fixed and processed for localization of labelled enzyme at the light and electron microscopic level by standard methods [33] .
Results
Five days after injection, animals which received only alloxan showed fasting blood glucose levels of 27.1_ 2.2 mmol/1. This level contrasted with that of 3.90___ 0.31 mmol/1 for saline controls, 4.84+0.55 mmol/1 for the SOD injection group and 3.08 _+ 0.55 mmol/l for the rats receiving SOD and alloxan.
Immunostaining of pancreatic islets for insulin, glucagon, and somatostatin in alloxan-diabetic animals ( Fig. 1) revealed a near absence of insulin 5 days following alloxan treatment, accompanied by a broadening pattern of glucagon staining throughout the islet. The proportion of somatostatin-positive cells appeared unchanged throughout the time period studied. Islets from SOD-treated animals and those which received both SOD and alloxan exhibited immunostaining for insulin, glucagon, and somatostatin which was the same as in control animals (Fig. 2 ).
At the electron microscopic level, following treatment with alloxan, many /3-cells showed extensive pathological changes at 30 min. Some cells contained an apparently increased population of secretion granules, others showed vacuolation of the rough endoplasmic reticulum and disrupted architecture, a and ~ cells in the alloxan groups appeared the same as those in the control groups.
Islet cells from animals treated with CuZn SOD or both CuZn SOD and alloxan did not differ from those of control animals. Typical fl granules (dense, round core with a very thin, lucent rim), a granules (dense core with a wide, lucent rim), and 6 granules (lightly-stained granules with no lucent rim) were visible (Fig. 3) . These secretory granules were similar in prevalence and structure in control rats and in experimental animals treated with CuZn SOD with and without alloxan. The cisternae of the rough endoplasmic reticulum and Golgi apparatus appeared similar in the latter three groups.
In autoradiographic studies with 125I labelled CuZn SOD, silver grains were occasionally observed at the electron microscopic level over the plasmalemma of/q cells and spaces bordering these and other islet cells (Figs.4a and 4b) . Silver grains were not encountered over cytoplasm or nucleus of any islet cells, indicating failure of labelled enzyme to enter the cell. However, 10-50min after injection of iodinated enzyme, radiolabel was evident in great abundance over the proximal convoluted tubules (Fig. 4 c) . At the ultrastructural level, the grains lay over brush borders and also overlaid forming and condensing reabsorption droplets of proximal renal tubules (Fig. 4 d) , indicating rapid renal clearance of the injected isotope. Labelling of hepatic Kupffer cells indicated participation also of the reticuloendothelial system in clearance of the enzyme.
Discussion
The high degree of vulnerability to alloxan of fl cells in the islets of Langerhans has been known since the reports by Dunn et al. [34, 35] . Our data agree with previous accounts of the selective demise of beta cells after alloxan treatment, showing the expected extensive damage to the fine structure of these cells [e. g. 20, 22] , particularly at the membrane level [18] .
However, we found no ultrastructural evidence for alloxan damage of/~ cells in rats pretreated with CuZn SOD. The normal abundance and structure of secretion granules in the fl cells in islets of animals treated with CuZn SOD and alloxan demonstrated that these cells were protected from alloxarl by the enzyme. These resuits provide morphological confirmation of the biochemical data [5, 8, 12, 13, 36] indicating that CuZn SOD prevents the induction of diabetes by alloxan and allows the ~ cells to remain fully functional.
Immunocytochemical staining for islet cell hormones in islets treated with CuZn SOD or with CuZn SOD and alloxan revealed no change from the normal islet morphology./3 cells were centrally located with a and ~ cells arranged around the periphery of each islet in both of these experimental groups. These staining patterns observed for the control, CuZn SOD-treated, and CuZn SOD-and alloxan-treated groups correspond with those reported by Erlandsen et al. [37] for normal rat islets of Langerhans.
The autoradiographic observations showed infrequent silver grains indicative of 1251 CuZn SOD location on the plasmalemma of islet cells and in spaces between these cells. Although the grains were so sparse as to make conclusive interpretation difficult, no intracellular grains were encountered and no evidence was ob-681 tained for SOD entering an islet cell. In preliminary correlated experiments with 14C-alloxan, 14C was localized in the cytoplasm of damaged fl cells (unpublished observations) in agreement with the general perception that alloxan or a metabolite enters the endocrine cells [7] . The apparent failure of labelled SOD to enter fl cells supports viewing the protective action of the enzyme as an extracellular event. Scavenging of oxygen radicals generated by alloxan at the cell surface may explain the protective action of CuZn SOD against alloxan-induced injury to/~ cells. While it is possible that SOD protected the islets against alloxan via some mechanism unrelated to scavenging of oxygen radicals [ for review see Cooperstein & Watkins, 38] , we feel this to be less likely, since the protective action of CuZn SOD is critically dependent on intact enzyme activity [12, 13] . The radioautographs also revealed abundant but transitory labelling of resorption droplets in the proximal nephron, and labelling of hepatic Kupffer cells. Rapid clearance of the injected enzyme is, therefore, mediated by a mechanism involving endocytosis and lysosomal degradation of the filtered protein in renal cells and in the reticuloendothelial system.
